首页> 外文OA文献 >Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

【2h】

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

机译：临床病理参数对新辅助多西紫杉醇和阿霉素化疗治疗的II / III期乳腺癌的预后影响：三阴性乳腺癌的悖论特征

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Kim Dong-Wan; Han Wonshik; Chie Eui; Lee Se-Hoon; Kim Jee; Oh Do-Youn; Kim Hee-Jun; Im Seock-Ah; Keam Bhumsuk; Moon Woo; Kim Tae-You; Park In; Noh Dong-Young; Heo Dae; Ha Sung; Bang Yung-Jue;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Impact of Neoadjuvant Chemotherapy in Stage II-III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates Surgical Results From CALGB 40603 (Alliance) [J] . Golshan Mehra, Cirrincione Constance T., Sikov William M., Annals of Surgery . 2015,第3期

机译：II-III期三阴性乳腺癌新辅助化疗对保乳手术资格和保乳率的影响CALGB 40603（联盟）的手术结果
2. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance) [J] . Sikov William M., Berry Donald A., Perou Charles M., Journal of Clinical Oncology . 2015,第1期

机译：在每周一次的紫杉醇新辅助治疗中加用卡铂和/或贝伐单抗后加剂量密集的阿霉素和环磷酰胺对II至III期三阴性乳腺癌病理完全缓解率的影响：CALGB 40603（联盟）
3. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance) [J] . Sikov William M., Berry Donald A., Perou Charles M., Journal of Clinical Oncology . 2015,第1期

机译：在每周一次的紫杉醇新辅助治疗中加用卡铂和/或贝伐单抗后加剂量密集的阿霉素和环磷酰胺对II至III期三阴性乳腺癌病理完全缓解率的影响：CALGB 40603（联盟）
4. Correlation based Feature Selection impact on the classification of breast cancer patients response to neoadjuvant chemotherapy [C] . S. Rosati, C. M. Gianfreda, G. Balestra, International Symposium on Medical Measurements and Applications . 2018

机译：基于相关特征选择对乳腺癌患者新辅助化疗反应分类的影响
5. Prognostic significance of some clinical, histopathological and biological parameters for survival of node-negative breast cancer patients treated in University Medical centre Maribor in the period 2000-2009 [D] . Fokter Dovnik, Nina. 2017

机译：2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床，组织病理学和生物学参数的预后意义
6. Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer [O] . Bhumsuk Keam, Seock-Ah Im, Hee-Jun Kim, 2007

机译：临床病理参数对新辅助多西他赛和阿霉素化疗治疗的II / III期乳腺癌的预后影响：三阴性乳腺癌的悖论特征
7. Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer [O] . Bhumsuk Keam, Seock-Ah Im, Hee-Jun Kim, 2007

机译：临床病理参数对新辅助多西紫杉醇和阿霉素化疗治疗的II / III期乳腺癌的预后影响：三阴性乳腺癌的悖论特征

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

著录项

相似文献

相关主题

期刊订阅